Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 1: Eradication of Helicobacter in the cachexia of idiopathic parkinsonism

Helicobacter

Volumn 10, Issue 4, 2005, Pages 267-275

  Dobbs, R John ^a,b   Dobbs, Sylvia M ^a,b   Weller, Clive ^a   Bjarnason, Ingua T ^a   Oxlade, Norman L ^a   Charlett, André ^a   Al Janabi, Mazin A ^a   Kerwin, Robert W ^a   Mahler, Robert F ^a   Price, Ashley B ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cachexia; Eradication; Etiology and pathogenesis; Helicobacter heilmannii; Helicobacter pylori; Idiopathic parkinsonism

Indexed keywords

AMOXICILLIN; ANTIPARKINSON AGENT; BACTERIUM ANTIBODY; CLARITHROMYCIN; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GENE PRODUCT; HYPNOTIC AGENT; INTERLEUKIN 6; LEVODOPA; METRONIDAZOLE; MIDAZOLAM; MONOAMINE OXIDASE INHIBITOR; OMEPRAZOLE; OXYTETRACYCLINE; RANITIDINE BISMUTH CITRATE; SEDATIVE AGENT; TETRACYCLINE; VACUOLATING TOXIN;

AGED; ARTICLE; BLOATING; BODY MASS; CACHEXIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DYSKINESIA; ERADICATION THERAPY; GASTRITIS; HELICOBACTER HEILMANNII; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHUMAN; PARKINSONISM; PEPTIC ULCER; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH EMPTYING; UNDERWEIGHT;

AGED; ANTI-BACTERIAL AGENTS; CACHEXIA; CHRONIC DISEASE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PARKINSON DISEASE; TREATMENT OUTCOME;

HELICOBACTER; HELICOBACTER HEILMANNII; HELICOBACTER PYLORI; PARKINSONIA;

EID: 23344451739     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2005.00331.x     Document Type: Article

References (32)

1. Dobbs SM, Dobbs RJ, Weller C, Charlett A. Link between Helicobacter pylori infection and idiopathic parkinsonism. Med Hypotheses 2000; 55:93-8.
2. Dobbs RJ, Charlett A, Dobbs SM, Weller C, Peterson DW. Parkinsonism: Differential age-trend in Helicobacter pylori antibody. Aliment Pharmacol Ther 2000;14:1199-205.
3. Dobbs SM, Oxlade N, Weller C, Dobbs RJ, Charlett A. Relationship of Helicobacter immunoblot antibody profile to predicted probability of having diagnosed idiopathic parkinsonism. Gut 2002;51 (Suppl. 11):77.
4. Bjarnason IT, Charlett A, Dobbs RJ, et al. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomised, double-blind, placebo-controlled efficacy study. Helicobacter 2005;10:276-87.
5. Strang RR. The association of gastro-duodenal ulceration with Parkinson's disease. Med J Austr 1965;52:842-3.
6. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-5.
7. Chen H, Zhang SM, Hernán MA, Willett WC, Ascherio A. Weight loss in Parkinson's disease. Ann Neurol 2003;53:676-9.
8. Levi S, Cox M, Lugon M, Hodkinson M, Tomkins A. Increased energy expenditure in Parkinson's disease. Br Med J 1990;301:1256-7.
9. Markus HS, Cox M, Tomkins AM. Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity. Clin Sci 1992;83: 199-204.
10. Toth MJ, Fishman PS, Poehlman ET. Free-living daily energy expenditure in patients with Parkinson's disease. Neurology 1997;48:88-91.
11. Charlett A, Dobbs RJ, Purkiss A, et al. Cortisol is higher in parkinsonism and associated with gait deficit. Acta Neurol Scand 1998;97:77-85.
12. Charlett A, Purkiss AG, Dobbs SM, Weller C, Peterson DW. Association of circulating TNF-α and IL-6 with ageing and parkinsonism. Acta Neurol Scand 1999;100:34-41.
13. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32:S125-7.
14. Chisholm SA, Owen RJ. Development and application of a novel screening PCR assay for direct detection of 'Helicobacter heilmannii'-like organisms in human gastric biopsies in Southeast England. Diagn Microbiol Infect Dis 2003;46:1-7.
15. Menzies IS, Zuckerman MJ, Nukajam WS, et al. Geography of intestinal permeability and absorption. Gut 1999;44:483-9.
16. Heilmann KL, Borchard F. Gastritis due to spiral shaped bacteria other than Helicobacter pylon: Clinical, histological, and ultrastructural findings. Gut 1991;32:137-40.
17. Yeomans ND, Kolt SD. Helicobacter heilmannii (formerly Gastrospirillum): Association with pig and human gastric pathology. Gastroenterology 1996;111:244-59.
18. Dobbs RJ, Bowes SG, Charlett A, Henley M, Frith C, Dickins J, et al. Hypothesis: The bradyphrenia of Parkinsonism is a nosological entity. Acta Neurol Scand 1993;87:255-61.
19. Malfertheiner P, Peitz U, Treiber G, et al. What constitutes failure for Helicobacter pylori eradication therapy? Can J Gastroenterol 2003;17:53B-57B.
20. Pierantozzi M, Pietroiusti A, Galante A, et al. Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients. Ann Neurol 2001;50:686-9.
21. Yeh S-S, Schuster MW. Geriatric cachexia. The role of cytokines. Am J Clin Nutr 1999;70:183-97.
22. 2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 2004;19:379-90.
23. Djaldetti R, Baron J, Ziv I, Melamed E. Gastric emptying in Parkinson's disease: Patients with and without response fluctuations. Neurology 1996;46:1051-4.
24. Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, Honigman S, Giladi N. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 2001;16:1041-7.
25. Charlett A, Dobbs RJ, Weller C, Dobbs SM. Stasis in the gut: The source of xenobiotic in idiopathic parkinsonism. Eur J Clinl Pharmacol 1997;52 (Suppl.):168.
26. Przuntek H, Müller TH, Reiderer P. Diagnostic staging of Parkinson's disease: Conceptual aspects. J Neural Transm 2004;111:201-16.
27. Eaker EV, Bixler GB, Dunn AJ, Moreshead WV, Mathias JR. Chronic alterations in jejunal myoelectric activity in rats due to MPTP. Am J Phsiol 1987;253:G809-G815.
28. Singaram C, Ashraf W, Gaumnitz EA, et al. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 1995;346:861-4.
29. Kupsky WJ, Grimes MM, Sweeting J, Bectsch R, Cote LJ. Parkinson's disease and megacolon: Hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 1987;37:1253-5.
30. Smith CAD, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-7.
31. Armstrong M, Daly AK, Cholerton S, Bateman N, Idle JR. Mutant debrisoquine hydroxylase genes in Parkinson's disease. Lancet 1992;339:1017-8.
32. Švec A, Kordas P, Pavlis Z, Novotny J. High prevalence of Helicobacter heilmannii-associated gastritis in a small, predominantly rural area: Further evidence in support of zoonosis? Scan J Gastroenterol;200:925-8.